{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06397677",
            "orgStudyIdInfo": {
                "id": "23-0295"
            },
            "secondaryIdInfos": [
                {
                    "id": "1R01HL168126-01",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1R01HL168126-01"
                }
            ],
            "organization": {
                "fullName": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "briefTitle": "Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease",
            "officialTitle": "Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease (MOUNTAIN)",
            "acronym": "MOUNTAIN",
            "therapeuticArea": [
                "Respiratory",
                "Orthopedics"
            ],
            "study": "defining-the-molecular-and-radiologic-phenotype-of-progressive-ra-interstitial-lung-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2034-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-12-01",
            "studyFirstSubmitQcDate": "2024-04-29",
            "studyFirstPostDateStruct": {
                "date": "2024-05-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                },
                {
                    "name": "University of California, San Francisco",
                    "class": "OTHER"
                },
                {
                    "name": "University of Michigan",
                    "class": "OTHER"
                },
                {
                    "name": "University of Kansas",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression.\n\nThe goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.",
            "detailedDescription": "The central hypothesis is that novel quantitative imaging and specific blood markers will be associated with progressive RA-ILD. The hypothesis will be tested through collection and analysis of peripheral blood, in addition to the analysis of HRCT (high-resolution computed tomography) scans performed as standard of care (clinical) on research subjects.\n\nProcedures performed:\n\nBaseline Year 0: Blood sample, buccal (cheek) swab, questionnaires and if performed clinically - Pulmonary Function tests, 6 Minute Walk Test, and HRCT scan of lungs\n\nEvery 4 months (at clinic visit): Blood sample, questionnaires\n\nYear 1 and Year 2 Follow-ups: Blood sample, buccal (cheek) swab, questionnaires and if performed clinically - Pulmonary Function tests, 6 Minute Walk Test, and HRCT scan of lungs"
        },
        "conditionsModule": {
            "conditions": [
                "Rheumatoid Arthritis",
                "Interstitial Lung Disease"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "24 Months",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Blood will be obtained for DNA (deoxyribonucleic acid), RNA (ribonucleic acid), serum, and plasma at baseline and at 12 months for all sites. For subjects enrolled in the study at the University of Colorado, peripheral blood samples will be obtained every 3-4 months. Samples not being directly assayed will be banked for future analysis."
            },
            "enrollmentInfo": {
                "count": 450,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Patients with RA-ILD",
                    "description": "Assessments include:\n\n* Clinical: height, weight, oxygen saturation at rest, and 6-minute walk test.\n* Rheumatological: study Rheumatologist will document rheumatoid arthritis symptoms and clinical findings at baseline and follow-up.\n* Pulmonary Function Testing: data will be collected from clinically performed spirometry and diffusing capacity for carbon monoxide.\n* High-resolution computed tomography (HRCT) imaging: HRCT scans will be collected at baseline and 12 months in line with standard of care for treatment of RA-ILD.\n* Lab specimens: peripheral blood will be obtained for DNA, RNA, serum, and plasma at baseline and at 12 months for all sites or every 3-4 months in Colorado. Buccal swabs (cheek) will also be collected once each year.\n* Information collected: will include demographics, co-morbidities, disease history, medication history, pulmonary function, radiographic imaging, and transplant/survival status through questionnaires and medical chart review.",
                    "interventionNames": [
                        "Genetic: Research Testing Performed (Laboratory)",
                        "Diagnostic Test: Information Collected as Standard of Care",
                        "Other: Research Testing Performed"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "Research Testing Performed (Laboratory)",
                    "description": "Blood collection (DNA, RNA)",
                    "armGroupLabels": [
                        "Patients with RA-ILD"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Information Collected as Standard of Care",
                    "description": "High Resolution CT Scan (Chest), Pulmonary Function Testing (PFT), 6-Minute Walk Test (6MWT)",
                    "armGroupLabels": [
                        "Patients with RA-ILD"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Research Testing Performed",
                    "description": "Blood collection (non-genetic), Buccal Swab, Rheumatologic Assessment, Pulmonary Assessment, Questionnaires",
                    "armGroupLabels": [
                        "Patients with RA-ILD"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Evaluating the role of novel quantitative imaging",
                    "description": "Through evaluation of baseline CT scans and application of novel quantitative technology, investigators will monitor for specific patterning to identify patients at risk for progression.",
                    "timeFrame": "5-years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Comparing peripheral blood telomere length (PB-TL)",
                    "description": "Investigators will test and validate if baseline peripheral blood telomere length (PB-TL) predicts a progressive phenotype in RA-ILD.",
                    "timeFrame": "5-years"
                },
                {
                    "measure": "Defining peripheral blood transcriptomic profiles",
                    "description": "Investigators will define and validate the peripheral blood transcriptomic profile of progressive RA-ILD.",
                    "timeFrame": "5-years"
                },
                {
                    "measure": "Exploring if a composite profile more accurately identifies progressive RA-ILD",
                    "description": "Investigators will use logistic least absolute shrinkage and selection operator (LASSO) to develop a predictive model of RA-ILD progression using demographics, novel imaging, PB-TL and peripheral blood transcriptome.",
                    "timeFrame": "5-years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria\n* 18 years of age or older\n\nExclusion Criteria:\n\n* Prior medication treatment specifically for RA-ILD\n* Inability to give informed consent\n* Pregnant women",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "90 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "RA-ILD study patients will be recruited from the University of Colorado Hospital, ILD Clinic (CU, PI: Joyce Lee, MD), in addition to the Rheumatology Clinic at the University of Colorado Hospital. Subjects will additionally be recruited from three unaffiliated ILD centers: University of California San Francisco (UCSF; site PI Dr. Paul Wolters), University of Kansas (KU, site PI Dr. Scott Matson), and University of Michigan (UM, site PI Dr. Justin Oldham).",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Haylie Lengel",
                    "role": "CONTACT",
                    "phone": "970-376-8303",
                    "email": "haylie.lengel@cuanschutz.edu"
                },
                {
                    "name": "Joyce S Lee",
                    "role": "CONTACT",
                    "phone": "303-724-6109",
                    "email": "joyce.lee@cuanschutz.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Joyce S Lee",
                    "affiliation": "University of Colorado, Denver",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Paul Wolters, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "University of Colorado Denver",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Haylie A Lengel",
                            "role": "CONTACT",
                            "phone": "970-376-8303",
                            "email": "haylie.lengel@cuanschutz.edu"
                        },
                        {
                            "name": "Joyce S Lee, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "University of Kansas",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66103",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Scott Matson, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                },
                {
                    "facility": "University of Michigan",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Justin Oldham, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000017563",
                    "term": "Lung Diseases, Interstitial"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4476",
                    "name": "Arthritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M4480",
                    "name": "Arthritis, Rheumatoid",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "asFound": "Lung Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19813",
                    "name": "Lung Diseases, Interstitial",
                    "asFound": "Interstitial Lung Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M5506",
                    "name": "Carbon Monoxide",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}